Role of hippocampal α2A-adrenergic receptor in methamphetamine-induced hyperlocomotion in the mouse

Neuroscience Letters

Volumn 341, Issue 2, 2003, Pages 156-160

  Nishio, Masahiro ^a   Kuroki, Yasutomi ^a   Watanabe, Yasuhiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Adrenergic receptor; Anti sense; Hippocampus; Locomotion; Methamphetamine

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; BRIMONIDINE; METHAMPHETAMINE; OLIGONUCLEOTIDE; YOHIMBINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HYPERACTIVITY; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; TISSUE DISTRIBUTION;

EID: 0037402802     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00171-X     Document Type: Article

References (20)

1. Beson M., Cheramy A., Feltz P., Glowinski J. Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat. Brain Res. 32:1971;407-424.
2. Correa-Sales C., Rabin B.C., Maze M. A hypnotic response to dexametetomidine, an alpha2-agonist, is mediated in the locus coeruleus in rats. Anaesthesiology. 76:1992;948-952.
3. Dennis T., L'Heureux R., Carter C., Scatton B.J. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release. J. Pharmacol. Exp. Ther. 241:1987;642-646.
4. Drouin C., Darracq L., Trovero F., Blanc G., Glowinski J., Cotecchia S., Tassin J.-P. α1b-Adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J. Neurosci. 22:2002;2873-2884.
5. Goto Y., O'Donnell P. Network synchrony in the nucleus accumbens in vivo. J. Neurosci. 21:2001;4498-4504.
6. Hertel P., Fagerquist M.V., Svensson T.H. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by α2-adrenoceptor blockade. Science. 286:1999;105-107.
7. Kobilka B.K., Matsui H., Kobilka T.S., Yang F.T., Francke U., Caron M.G., Lefkowitz R.J., Regan J.W. Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. Science. 238:1987;650-656.
8. Kuroki Y., Fukushima K., Kanda Y., Mizuno K., Watanabe Y. Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampus. Eur. J. Neurosci. 13:2001;472-476.
9. Mavridis M., Colpaert F.C., Millan M.J. Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists. Brain Res. 562:1991;216-224.
10. o in mice. Neurosci. Lett. 334:2002;145-148.
11. Nunes J.P. Central alpha2-adrenoceptor and blood pressure regulation in the rat. Eur. J. Pharmacol. 278:1995;183-185.
12. Regan J.W., Kobilka T.S., Yang F.T., Caron M.G., Lefkowitz R.J., Kobilka B.K. Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proc. Natl. Acad. Sci. USA. 85:1988;6301-6305.
13. Sallinen J., Haapalinna A., Viitamaa T., Kobilka B.K., Scheinin M. D-Amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype. Neuroscience. 86:1998;959-965.
14. Sallinen J., Link R.E., Haapalinna A., Viitamaa T., Kulatunga M., Sjoholm B., Macdonald E., Pelto H.M., Leino T., Barsh G.S., Kobilka B.K., Scheinin M. Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist. Mol. Pharmacol. 51:1997;36-46.
15. Schramm N.L., McDonald M.P., Limbird L.E. The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J. Neurosci. 21:2001;4875-4882.
16. Unekage T., Namima M., Fukushima K., Sugita S., Watanabe Y. c-fos antisense blocks methamphetamine-induced ambulatory activity reversibly. NeuroReport. 8:1997;407-410.
17. Von Voigtlander P.F., Moore K.E. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine. J. Pharmacol. Exp. Ther. 184:1973;542-552.
18. Wang X.-B., Funada M., Imai Y., Revay R.S., Ujike H., Vandenbergh D.J., Uhl G.R. rGβ1: a psychostimulant-regulated gene essential for establishing cocaine sensitization. J. Neurosci. 17:1997;5993-6000.
19. Weinshank R.L., Zgombick J.M., Macchi M., Adham N., Lichtblau H., Branchek T.A., Hartig P.R. Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor. Mol. Pharmacol. 38:1990;681-688.
20. Wortley K.E., Hughes Z.A., Heal D.J., Stanford S.C. Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by α2-adrenoceptors. Br. J. Pharm. 127:1999;1860-1866.